A NOS inhibitor aminoguanidine reduces zinc-induced neuron loss in rat hippocampus

Neuroscience Research Communications

Volumn 33, Issue 1, 2003, Pages 53-62

  Gokce F M ^a   Bagirici F ^a   Kaplan, S ^a   Demir, S ^a   Ayyildiz, M ^a   Marangoz, C ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Aminoguanidine; Hippocampus; Nitric oxide; Rat; Stereology; Zinc

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM CHLORIDE; ZINC SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DEATH; CELL LOSS; CONTROLLED STUDY; DEGENERATIVE DISEASE; HIPPOCAMPUS; MALE; NEUROTOXICITY; NONHUMAN; PYRAMIDAL NERVE CELL; RAT;

EID: 0043236036     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/nrc.10080     Document Type: Article

References (47)

1. Chvapil M, Elias SL, Ryan JN, Zukoski CF. Pathophysiology of zinc. In: Pfeiffer CC (ed) Neurobiology of trace metals zinc and copper, 2nd Ed, Vol. 1. Academic, New York, 1972. pp 105-124.
2. Pei Y, Koyama I. Features of seizures and behavioral changes induced by intrahippocampal injection of zinc sulfate in the rabbits: a new experimental model of epilepsy. Epilepsia 1986; 27: 183-188.
3. Lees GJ, Lehmann A, Sandberg M, Hamberger A. The neurotoxicity of zinc in the rat hippocampus. Neurosci Lett 1990; 120: 155-158.
4. Horning MS, Blakemore LJ, Trombley PQ. Endogenous mechanisms of neuroprotection: role of zinc, copper, and carnosine. Brain Res 2000; 852: 56-61.
5. Takeda A. Movement of zinc and its functional significance in the brain. Brain Res Rev 2000; 34: 137-148.
6. Sloviter RS. A selective loss of hippocampal mossy fiber Timm stain accompanies granule cell seizure activity induced by perforant path stimulation. Brain Res 1985; 330: 150-153.
7. Suh SW, Listiack K, Bell B, Chen J, Motamedi M, Silva D, Dancher G, Whetsell W, Thompson R, Frederickson C. Detection of pathological zinc accumulation in neurons: methods for autopsy, biopsy, and cultured tissue. J Histochem Cytchem 1999; 47: 969-972.
8. Demir Ş, Baǧiri F, Marangoz C. A calcium channel blocker nicardipine protects neurons from zinc-induced toxicity in rat hippocampus. Neurosci Res Cummun 2000; 30: 135-141.
9. Marangoz C, Aǧar E, Ayyildiz M, Taşçi N. Decreasing in pyramidal cell density after intracortical zinc sulphate administration in rat hippocampus. Tr J Medical Sciences 1990; 14: 231-237.
10. Marangoz C, Ayyildiz M, Taşçi N. Phenobarbital protects neurons against toxicity induced by intracortical zinc. Tr J Medical Sciences 1991; 15: 378-383.
11. Kress Y, Gaskin F, Brosman CF, Levine S. Effects of zinc on the cytoskeletal proteins in the central nervous system of the rat. Brain Res 1981; 220: 139-149.
12. Gaskin F, Kress Y, Brosman C, Bornstein M. Abnormal tubulin, aggregates induced by zinc sulphate in organotypic cultures of nerve tissue. Neuroscience 1981; 3: 1117-1128.
13. Amaral D, Witter MP. The three-dimensional organisation of the hippocampal formation: a review of anatomical data. Neuroscience 1989; 31: 571-591.
14. Gibaldi M. What is nitric oxide and why are so many people studying it? J Clin Pharmacol 1993; 33: 488.
15. Huang AM, Lee EHY. Role of hippocampal nitric oxide in memory retention in rats. Pharmacol Biochem Behav 1995; 50: 327-332.
16. Shibata M, Araki N, Ohta K, Hamada J, Shimazu K, Fukuuchi Y. Nitric oxide regulates NMDA-induced dopamine release in rat striatum. Neuroreport 1996; 7: 605-608.
17. Hölscher C. Nitric oxide the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci 1997; 20: 298-303.
18. Frandsen A, Andersen CF, Schousboe A. Possible role of cGMP in excitatory amino acid induced cytotoxicity in cultured cerebral cortical neurons. Neurochem Res 1992; 17: 35-43.
19. Verrecchia C, Boulu RG, Plotkine M. Neuroprotective and deleterious effects of nitric oxide on focal cerebral ischemia-induced neuron death. Adv Neuroimmunol 1995; 5: 359-378.
20. Baǧirici F, Marangoz C. Proconvulsant effects of central and peripheral administration of L-NAME on penicillin-induced epilepsy in rats. Neurosci Res Cummun 2001; 28: 107-114.
21. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997; 17: 9157-9164.
22. Iadecola C, Zhang F, Xu X. Inhibition of inducible nitric oxide synthase gene expression in brain following focal cerebral ischemia. Am J Physiol 1995; 268: 286-292.
23. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100: 2417-2423.
24. Griffiths MJD, Messent M, Curzen NP, Evans TW. Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase. Am J Res Crit Care Med 1995; 152: 1599-1604.
25. Leib SL, Kim YS, Black SM, Tureen JH, Tauber MG. Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J Infect Dis 1998; 177: 692-700.
26. Zhang F, Iadecola C. Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage. Brain Res 1998; 802: 104-110.
27. Cockroft KM, Meistrell M, Zimmerman GA, Risucci D, Bloom O, Cerami A, Tracey KJ. Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke 1996; 27: 1393-1398.
28. Baǧirici F, Genç H, Tan F, Demir Ş. Neuroprotective effect of nicardipine on cadmium-induced Purkinjc cell death in rat cerebellum. Neurosci Res Cummun 2001; 29: 99-105.
29. Herguido HJ, Carceller F, Roda JM, Avendaño C. Hippocampal cell loss in transient global cerebral ischemia in rats: a critical assessment. Neuroscience 1999; 93: 71-80.
30. Iadecola C, Zhang F, Casey R, Clark HB, Ross ME. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 1996; 27: 1373-1380.
31. West MJ, Slomianka L, Gundersen HJG. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991; 231: 482-497.
32. Kaplan S, Canan S, Aslan H, Ünal B, Şahin B. A simple technique to measure the movements of the microscope stage along the x and y axes for stereological methods. J Microsc 2001; 203: 321-325.
33. Gundersen HJG. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones in memory of William R Thomson. J Microsc 1986; 143: 3-45.
34. C. Schmitz, Variation of fractionator estimates and its prediction. Anat & Embryol 1998; 198: 371-397.
35. Suh SW, Chen JW, Motamedi M, Bell B, Listiak K, Pons NF, Danscher G, Frederickson CJ. Evidence that synaptically released zinc contributes to neuronal injury after traumatic brain injury. Brain Res 2000; 852: 268-273.
36. Frederickson CJ, Hernandez MD, McGinty JF. Translocation of zinc may contribute to seizures-induced death of neurons. Brain Res 1989; 480: 317-321.
37. Yin HZ, Weiss JH. Zn2+ permeates Ca2+ permeable AMPA/kainite channels and triggers selective neuronal injury. Neuroreport 1995; 6: 2553-2556.
38. Hambidge, KM. Zinc. In: Mertz W (ed) Trace elements in human and animal nutrition, Vol 1. Academic, San Diego, 1987. pp 1-137
39. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacological and chemical properties that are identical to those for nitric oxide radical. Circ Res 1987; 61: 866-879.
40. Heneka MT, Loschmann PA, Gleichmann M, Weller M, Schulz JB, Wullner U, Klockgether T. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumour necrosis factor-alpha/lipopolysaccharide. J Neurochem 1998; 71: 88-94.
41. Inoue M, Ohgiya N, Yamamoto M. Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats. Brain Res 1998; 800: 319-322.
42. Weiss JH, Hartley DM, Koh S-Y, Choi DW. AMP receptor activation potentiates zinc neurotoxicity. Neuron 1993; 10: 1-20.
43. Donaldson J, St. Pierre J, Minnich J, Barbeau A. Seizures in rats associated with divalent cation inhibition of Na-K-ATPase. Can J Biochem Cell Biol 1971; 49: 1217-1224.
44. Pei Y, Zhao D, Huang J, Cao L. Zinc-induced seizures, a new experimental model of epilepsy. Epilepsia 1983; 24: 169-176.
45. Oorschot DE. Are you using neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go. Prog Neurobiol 1994; 44: 233-274.
46. O'Neill MJ, Hicks C, Ward M, Panetta J.A. Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia. Brain Res 1997; 760: 170-178.
47. Zhao W, Tilton RG, Corbett JA, McDaniel ML, Misko TP, Williamson JR, Cross AH, Hickey WF. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol 1996; 64: 123-133.